Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Biomaterials. 2017 May 11;137:11–22. doi: 10.1016/j.biomaterials.2017.05.019

Figure 6.

Figure 6

In vivo efficacy of Celludo against NCI-ADR RES peritoneal metastatic tumor model. NCI-ADR RES cells were implanted i.p. in the SCID mice. Three weeks after of inoculation, mice were treated with either saline, PPT, PTX, PEGylated liposomal doxorubicin (PLD) or Celludo. A. Percent survival over time; B. Change in body weight over time.